|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1956-11-01 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1955-04-28 |
靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
非在研适应症- |
最高研发阶段撤市 |
|
首次获批日期1982-01-01 |
Active-Controlled Trial of the Safety and Tolerability of MP29-02 in Subjects with Chronic Allergic or Nonallergic Rhinitis
Active-Controlled Trial of the Safety and Tolerability of MP03-33 in Patients with Chronic Allergic or Nonallergic Rhinitis - NA
Active-Controlled Trial of the Safety and Tolerability of MP03-33 (Nasal Spray) in Patients with Chronic Allergic or Nonallergic Rhinitis
100 项与 Medpointe Pharmaceuticals 相关的临床结果
0 项与 Medpointe Pharmaceuticals 相关的专利(医药)
100 项与 Medpointe Pharmaceuticals 相关的药物交易
100 项与 Medpointe Pharmaceuticals 相关的转化医学